
==== Front
BMC Infect Dis
BMC Infect Dis
BMC Infectious Diseases
1471-2334
BioMed Central London

39251906
9835
10.1186/s12879-024-09835-7
Research
Human adenovirus type 4 (HAdV-4) associated acute respiratory tract infection in children & genetic characteristics of HAdV-4 in China: a prospective multicenter study
Wang Jinjin 1
Feng Qianyu 1
Duan Yali 1
Ai Junhong 1
Zhu Yun 1
Wang Ran 1
Chen Xiangpeng 1
Lu Gen 2
Sun Yun 3
Li Changchong 4
Jin Rong 5
Shang Yunxiao 6
Xu Baoping 7
Xie Zhengde xiezhengde@bch.com.cn

1
1 grid.24696.3f 0000 0004 0369 153X Beijing Key Laboratory of Pediatric Respiratory Infection diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045 China
2 https://ror.org/01g53at17 grid.413428.8 0000 0004 1757 8466 Department of Respiratory, GuangZhou Women and Children’s Medical Center, GuangZhou, 510623 China
3 Department of General Pediatrics, Yinchuan Women and Children Healthcare Hospital, Yinchuan, 750002 China
4 grid.417384.d 0000 0004 1764 2632 Department of Respiratory, the 2nd Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325027 China
5 https://ror.org/0389fv189 grid.410649.e Department of Respiratory, Guiyang Maternal and Child Health Hospital, Guiyang, 550003 China
6 grid.412467.2 0000 0004 1806 3501 Department of Pediatric Respiratory, Shengjing Hospital of China Medical University, Shenyang, 110004 China
7 grid.24696.3f 0000 0004 0369 153X National Clinical Research Center for Respiratory Diseases, Department of Respiratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045 China
9 9 2024
9 9 2024
2024
24 93621 5 2024
28 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Human adenovirus (HAdV) is an important pathogen causing acute respiratory infection (ARI) in children. Many countries, including China, have experienced sporadic or outbreaks related to HAdV-4, and death cases were reported. However, there is little research on HAdV-4 and the epidemic situation of HAdV-4 in China is little known. This study was designed to comprehend the prevalence and genetic characteristics of HAdV-4 in ARI children in China.

Methods

Respiratory tract samples from ARI children hospitalized in six hospitals of Northern and Southern China from 2017 to 2020 were collected for HAdV detection and typing. Clinical information was collected from HAdV-4 positive patients for clinical characteristics and epidemiological analysis. The main capsid proteins and the whole genome sequences were amplified and sequenced for bioinformatics analysis.

Results

There were 2847 ARI children enrolled, and 156 (5.48%) HAdV positive samples were detected. Eleven HAdV-4 positive samples were identified, accounting for 0.39% of the total samples and 7.05% of the HAdV positive samples. The main manifestations were fever and cough. Two children had conjunctivitis. Two children were diagnosed with severe pneumonia and developed respiratory failure. One of them developed hemophagocytic syndrome and checked in pediatric intensive care unit (PICU). This child had ventricular septal defect. All the children recovered. The isolated strains of HAdV-4 obtained in this study and the reference strains from China located in the same phylogenetic branch (HAdV-4a), while the prototype strain and vaccine strains formed another branch (HAdV-4p). Upon comparison with the prototype strain, there were a few amino acid mutations existing in three major capsid proteins. According to recombination analysis, no new recombination was found.

Conclusions

The detection rate of HAdV-4 in children hospitalized with ARI was 0.39% in the total samples and 7.05% of all HAdV positive samples. HAdV-4 isolates obtained in this study and other reference strains from China belonged to the HAdV-4a subtype. Our data provided reference for the monitoring, prevention and control of HAdV-4, as well as the research and development of vaccines and drugs.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12879-024-09835-7.

Keywords

Human adenovirus type 4
Acute respiratory infection
Clinical characteristics
Genetic characteristics
Children
National Natural Science Foundation of China82072266 National Science and Technology Major Special Project2017ZX10103004­004 CAMS Innovation Fund for Medical Sciences (CIFMS)2019-I2M-5-026 issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Human adenovirus (HAdV) belongs to the Mastadenovirus genus of the Adenoviridae family, and is a linear double-stranded deoxyribonucleic acid (DNA) virus without envelope. The diameter is about 70–100 nm, and the total genome length is about 36kb [1]. The capsid of the HAdV is icosahedral symmetric and consists of the main capsid proteins (Hexon, Penton base, and Fiber) as well as secondary capsid proteins [2]. The Hexon protein contains two hypervariable domains, Loop1 (including the hypervariable region 1–6) and Loop2 (including the hypervariable region 7), which are the main target regions for inducing neutralizing antibodies and form ε antigen epitopes. The ε antigen epitopes are group-specific and type-specific, and are the basis for virus serum neutralization experiments and type identification [3]. The Penton base protein has two key sites, including the Arg-Gly-Asp (RGD) Loop and the hypervariable region (HVR) 1 region. The former is located in the hypervariable loop 2 region. The interplay between this region and the integrin expressed on the host cell surface is conducive to the virus internalization and thus promoting the virus infection [2]. The latter lies on the surface of the virus capsid, and recombination can occur at this site and its vicinity [4]. The Fiber protein contains N-terminal tail (Tail), stalk (Shaft), and C-terminal spherical domain nodules (Knob). Knob region can mediate the interaction between the virus and host cells [3]. So far, HAdV is separated into 7 species from A to G, including 116 types (http://hadvwg.gmu.edu/). HAdV is one of the important pathogens causing acute respiratory infection (ARI) in children, and the detection rate is about 5-10% [5], which can reach 20.1% in severe ARI children [6]. The treatment of HAdV infection is mainly symptomatic and supportive therapies, and there is no approved specific antiviral drug. In severe cases, HAdV infection can be fatal. Especially in infants and children with immunodeficiency or immunosuppression, HAdV infection can lead to serious clinical manifestations and long-term sequelae such as airway occlusion and bronchiectasis, posing a serious threat to children’s lives and health [7, 8]. The tissue tropism of different types of HAdV is different, which can lead to different illnesses. The main types related to respiratory infections are B species (HAdV-3, 7, 11, 14, 16, 21, 50, and 55), C species (HAdV-1, 2, 5, and 6), and E species (HAdV-4) [1].

HAdV-4 is one of the common types causing ARI, which is the only member of the E species. The prototype strain (RI-67 strain) was first isolated from an ARI case during the influenza pandemic in Fort Leonard Wood (Missouri, USA) in 1953 [9]. HAdV-4 is mostly sporadic, but it can also cause local small-scale epidemics or large outbreaks, with death cases reported [1]. In 1980, Faden et al. reported a case of a 5-and-a-half-year-old child with a previous history of epilepsy dying from respiratory distress caused by HAdV-4 infection in USA [10]. Ou et al. detected 16 positive cases of HAdV in the lung tissues of 175 children who died of pneumonia at Guangzhou Children’s Hospital from July 1988 to January 2005 by using nested polymerase chain reaction (PCR) and immunohistochemical analysis methods, among which 12 cases were of HAdV-4, accounting for 75%, indicating that it might be an important serotype for fatal pneumonia in children in Guangzhou [11]. In September 2013, an outbreak of ARI caused by HAdV-4 occurred in a kindergarten in Longgang District, Shenzhen, China. There were 17 cases of infection, including 4 hospitalized cases, all of which were 5-year-old children [12]. In recent years, the incidence rate related to HAdV-4 has gradually increased in many countries, including China, so it is considered to be one of the reasons for the major epidemic [13]. Coleman et al. performed genome sequencing on HAdV positive clinical samples collected from 396 pediatric patients in Singapore and found that compared with 2014–2015, the risk of HAdV-4 infection increased among pediatric patients admitted to Singapore General Hospital and KK Women’s and Children’s Hospital from 2016 to 2018 (OR, 13.6 [3.9–46.7]) [14]. Chen et al. found that among children hospitalized for ARI in Southern Taiwan, type 3 and 7 were the main types between November 1999 and March 2000, and from then on to 2001, type 4 became the main type, accounting for approximately 52% of the total number of HAdVs detected [15]. Ye et al. showed that the serum antibody positivity rate of HAdV-4 in healthy individuals in Southern China was 58.4%, and increased with age [16]. Recently, some studies have reported that HAdV-4 may have a new recombination phenomenon. Zhang et al. found that the HAdV-4 strain obtained in Hong Kong in 2014 might have undergone recombination of inverted terminal repeat sequences (ITRs), acquiring human transcription factor binding sites nuclear factor 1 (NF-1) from the internal ITRs of B species (3, 7, 14, 16, 21, 55), which was more conducive to replication and growth of HAdV-4 in human cells [17, 18]. Based on restriction enzyme analysis (REA), the HAdV-4 genotypes can be divided into two subtypes: HAdV-4p and HAdV-4a [19]. The Fiber protein of the HAdV-4 has the regions binding to Coxsackie-adenovirus receptor (CAR) that mediates the adhesion between HAdV-4 and target cells, which is a rate-limiting factor of HAdV-4 transfection into target cells [20].

As of now, there are few sequences of HAdV-4 strains from China. Only thirteen whole genome sequences of HAdV-4 published in GenBank are from China. The epidemic situation of HAdV-4 in China is little known [1, 21]. Although vaccines for HAdV-4 have been developed, they are only used in American military recruits. Currently, in China, there are no HAdV-4-related vaccines or drugs with safety and effectiveness applied [22]. In this study, the purpose was to clarify the prevalence and genetic characteristics of HAdV-4 in China, and provide data reference for the monitoring, prevention and control of HAdV-4, as well as the research and development of vaccines and drugs. ARI children hospitalized in six hospitals across six provinces in Northern and Southern China during 2017 and 2020 were selected as the research subjects. The clinical data of HAdV-4 positive patients were collected for clinical feature analysis, and bioinformatics analyses on the whole genome sequences, Hexon, Penton base, Fiber, and ITR gene sequences were conducted.

Methods

Patients and clinical data collection

A multicenter study was performed with children younger than 18 years hospitalized for ARI from 2017 to 2020. Patients were enrolled from six areas (Beijing, Guangzhou, Wenzhou, Yinchuan, Guiyang, and Shenyang) in Northern and Southern China. Children with ARI after 48 h of admission or recent history of HAdV infection were excluded. The clinical electronic medical record system was used to collect the clinical data.

Specimen collection and HAdV detection and typing

Respiratory samples including sputum (0.5 ml) and nasal/pharyngeal swabs were collected within 24 h after hospitalization. The sputum was stored in 3 ml virus transport solution, and the nasal/pharyngeal swabs were immersed in virus sampling tubes containing 3 ml virus transport solution (Yocon Hengye Biotechnology, Beijing, China). The samples were transported to laboratories of various hospitals for processing at low temperature (4 °C) and were divided into three parts and stored in the − 80 °C refrigerator. Ultimately, these samples were transported to virology laboratory of the Beijing Children’s Hospital affiliated to Capital Medical University through dry ice for centralized detection and analysis. The QIAamp MinElute Virus Spin Kit (QIAGEN, Hilden, Germany) was used to extract viral nucleic acids following the manufacturer’s instructions. The Multiple Respiratory Virus Panel (RVP) (Luminex Corporation, USA) was used to detect common respiratory viruses, including human enterovirus (HEV), human rhinovirus (HRV), respiratory syncytial virus (RSV), parainfluenza virus, HAdV, coronavirus, influenza virus, human bocavirus, and human metapneumovirus (HMPV), etc. For specimens tested HAdV positive, the amplification of the HVR 1–6 of the Hexon gene was completed by nested PCR (HotStar Taq Plus Master Mix Kit, QIAGEN, Germany) following the instructions [23]. The primers and amplified fragments are shown in Supplementary Table 1. The purification and sequencing of PCR products were performed by Sino Geno Max (Beijing, China). BLAST was used to align the sequencing results with the sequences in GenBank to determine the typing.

Virus isolation and sequencing of whole genome

To isolate the virus, the HEp-2 cells were used, onto which the HAdV-4 positive samples inoculated. The obtained nucleic acids of the strains were sent to BioGerm Medical Technology (Shanghai, China) to obtain the whole genome sequences using second-generation sequencing technology, which were annotated and uploaded to the GenBank database.

Amplifying and sequencing of major capsid proteins and ITR gene

HotStar Taq Plus Master Mix Kits (QIAGEN, Hilden, Germany) was used to perform PCR amplification to obtain full-length sequences of Hexon, Penton base, and Fiber genes following the instructions. The primers are shown in Supplementary Table 2. Based on Sanger sequencing, the sequencing of PCR products was performed by Sino Geno Max (Beijing, China). DNASTAR v7.1 (DNASTAR Inc., Madison, WI, United States) was used to assemble and edit the sequences. The obtained Hexon, Penton base, and Fiber genes were annotated and uploaded to the GenBank database. Using genomic DNA as a template, the ITR genes were sequenced with either a 5’-primer “HAdV-4-ITR-F” (5’-AACTCTTCTCGCTGGCACTCAA-3’) or a 3’-primer “HAdV-4-ITR-R” (5’-CCGCCCCTAACAGTCGCC-3’) [17].

Phylogenetic analysis

The GenBank database was used to select the reference sequences of the whole genome, Hexon, Penton base, and Fiber genes of HAdV-4 to perform phylogenetic analysis. The whole-genomic sequences that were not typed based on three major capsid protein genes and lacked isolation time and location and the Hexon, Penton base, and Fiber gene sequences with high consistency in region, time and sequence were excluded. The ITR sequences were extracted from the whole-genomic reference sequences of HAdV-4 obtained above, and the representative ITR reference sequences of the other types of HAdV were selected from GenBank. Multiple alignment of the whole-genomic sequences and Hexon, Penton base, Fiber, ITR genes was carried on by MAFFT (https://www.ebi.ac.uk/Tools/msa/mafft/) software. By MEGA v7.0.26 (Sudhir Kumar, Arizona State University, Tempe, AZ, United States) software, the phylogenetic trees were constructed using the neighbor-joining method and the Kimura two-parameter model. To evaluate the reliableness of the phylogenetic trees, the bootstrap method with 1,000 replicates was used.

Analysis of genetic variation

BioEdit v7.2.05 software (http://www.mbio.ncsu.edu/BioEdit/page2.html) was used to determine the genetic variations of the Hexon, Penton base, and Fiber genes of HAdV-4 obtained in this study.

Recombination analysis

Based on the whole-genomic sequences of the HAdV-4, recombination analysis was performed by Simplot v3.5.1 software. The window size, step size, distance model and tree model which were defaulted to 1,000, 200, “Kimura”, and “Neighbor-Joining”, respectively, were employed for the analysis.

Ethics

The Institutional Ethics and Review Committees of the Beijing Children’s Hospital affiliated to Capital Medical University approved this study (2017-k-15, 2019-k-357), which was conducted in accordance with the Declaration of Helsinki (revised in 2013). Parents/legal-guardian of each child signed an informed consent.

Results

Enrolled patients

After further excluding children with missing or duplicate clinical data or unqualified respiratory samples collected, 2847 ARI children were finally enrolled, of which 1407 (49.42%) patients were from Northern China and 1440 (50.58%) were from Southern China. The detailed geographical distribution of ARI children is shown in Table 1. The distribution of the gender and age is shown in Table 2. There were 1723 males (60.52%) and 1124 females (39.48%), with a proportion of 1.53: 1.

Table 1 Distribution of 2847 ARI patients in different areas of mainland China and the detection rate of HAdV

Area	ARI patients (%)	HAdV (%)	HAdV-1 (%)	HAdV-2 (%)	HAdV-3(%)	HAdV-4 (%)	HAdV-5 (%)	HAdV-6(%)	HAdV-7 (%)	
Total	2847	156 (5.48)	4 (2.56)	9 (5.77)	38 (24.36)	11 (7.05)	2 (1.28)	1 (0.64)	33 (21.15)	
North										
Beijing	703 (24.69)	32(4.55)	0	1 (3.13)	8 (25)	9 (28.13)	0	0	6 (18.75)	
Shenyang	200 (7.02)	5 (2.50)	0	0	2 (40)	0	0	0	1 (20)	
Yinchuan	504 (17.70)	23 (4.56)	0	0	10 (43.48)	0	0	0	1 (4.35)	
Total	1407 (49.42)	60 (4.26)	0	1 (1.67)	20 (33.33)	9 (15)	0	0	8 (13.33)	
South										
Guiyang	393 (13.80)	17 (4.33)	1 (5.88)	1 (5.88)	3 (17.65)	0	0	1 (5.88)	2 (11.76)	
Guangzhou	600 (21.07)	41 (6.83)	1 (2.44)	1 (2.44)	7 (17.07)	2 (4.88)	1 (2.44)	0	12 (29.27)	
Wenzhou	447 (15.70)	38 (8.50)	2 (5.26)	6 (15.79)	8 (21.05)	0	1 (2.63)	0	11 (28.95)	
Total	1440 (50.58)	96 (6.67)	4 (4.17)	8 (8.33)	18 (18.75)	2 (2.08)	2 (2.08)	1 (1.04)	25 (26.04)	

Table 2 Demographic characteristics of 2847 ARI children

	Total (%)	North (%)	South (%)	
Gender				
Male	1723(60.52)	794(56.43)	929(64.51)	
Female	1124(39.48)	613(43.57)	511(35.49)	
Age				
Median (years)	2.08	2.41	2.01	
< 6 months	598(21.00)	147(10.45)	451(31.32)	
6 months ~ < 1 year	458(16.09)	144(10.23)	314(21.81)	
1 ~ < 3 years	698(24.52)	299(21.25)	399(27.71)	
3 ~ < 6 years	599(21.04)	412(29.28)	187(12.99)	
≥ 6 years	494(17.35)	405(28.78)	89(6.18)	

Detection rate of HAdV and HAdV-4

The detection rate of HAdV is shown in Table 1. There were 156 (5.48%) HAdV positive samples detected, of which 67 were co-infected with other common respiratory viruses. forty-two cases were co-infected with one virus, eighteen cases were co-infected with two viruses, and 7 cases were co-infected with three viruses. The most common co-infection viruses were RSV (18 cases), HMPV (13 cases), and HEV and/or HRV (19 cases). Ninety-eight HAdV positive samples were successfully genotyped, and three species (B, C, and E) were detected, including seven genotypes (HAdV-1 ~ 7). The detection rates of seven genotypes of HAdV are shown in Table 1. Eleven HAdV-4 positive samples were detected, accounting for 0.39% of the total number of samples and 7.05% of the HAdV positive samples, respectively. The specific information of 11 HAdV-4 positive samples is shown in Table 1 and Supplementary Table 3. There were 2 cases (18.18%, 2/11) in 2017, 3 cases (27.27%, 3/11) in 2018, 5 cases (45.45%, 5/11) in 2019, and 1 case (9.10%, 1/11) in 2020.

Clinical characteristics of patients with HAdV-4 infection

The clinical characteristics of 11 patients with HAdV-4 infection are shown in Supplementary Table 4. Children aged < 6 months, 6 months-1 year, 1–3 years, 3–6 years, and 6–12 years made up 18.2% (2/11), 9% (1/11), 27.3% (3/11), 18.2% (2/11), and 27.3% (3/11), respectively. Six children were female and 5 children were male. All the 11 children had cough and 10 children (90.91%) developed fever, with a peak fluctuation of 38.2–40℃. Two children (18.18%) had conjunctivitis. Three children (27.27%) had shortness of breath and wheezing, among which 2 children had dyspnea and required nasal continuous positive airway pressure (NCPAP) respiratory support, as well as serious complications such as respiratory failure and mild elevation of liver enzymes. These two children were diagnosed with severe pneumonia, one of which developed hemophagocytic syndrome and checked in pediatric intensive care unit (PICU). The patient had a potential disease of ventricular septal defect and the longest hospital stay. Four patients (36.36%) experienced increased white blood cell. Six patients (54.55%) had increased procalcitonin and erythrocyte sedimentation rate, and 7 patients (63.64%) had increased C reactive protein. All patients had different degrees of chest X-ray abnormalities. Eight children (72.73%) were diagnosed with pneumonia, 1 child (9.09%) with bronchitis, and 2 children (18.18%) with upper respiratory tract infection (URTI). There was 1 child (9.09%) with mixed infection of HRV. Two children diagnosed with severe pneumonia did not have any other pathogenic infections. The total hospitalization time varied from 4 to 24 days. All the patients improved and were discharged without any deaths.

Phylogenetic analysis of the whole genome of HAdV-4

Two HAdV-4 strains were isolated from patients from Guangzhou, and the whole-genome sequences were obtained (Supplementary Table 3), of which the identities of the nucleotide and amino acid sequences were 99.9% and 100%, respectively. The genetic distance was 0.000. One hundred and thirty-four HAdV-4 whole-genomic reference sequences were obtained (Supplementary Table 5) from Genbank.

There were two phylogenetic branches of HAdV-4 according to the whole-genome sequence phylogenetic analysis: 4a and 4p. The two whole-genome sequences obtained in this study were located in the same branch (4a) as the thirteen HAdV-4 whole-genome reference sequences currently available in China, as well as most prevalent strains worldwide since the 1980s. The prototype strain (Genbank accession number: AY594253) and vaccine strains were in the same branch (4p) as most of the prevalent strains before the 1980s and several strains discovered in USA after that (Fig. 1). All the whole-genome sequences of HAdV-4 in China were clustered together, with the Bootstrap value of 97%, nucleotide and amino acid sequence identities of 96.6–100% and 96.5–100%, respectively, and the genetic distance of 0.000. The nucleotide and amino acid sequence identities on the whole-genome sequences of the HAdV-4 isolates obtained in this study and recent epidemic strains in China were 98.2–99.9% and 98-99.8%, respectively, with the genetic distance of 0.000. The mean genetic distances within group of 4a and 4p were 0.001, respectively, and the mean genetic distance between groups of 4a and 4p was 0.038. These findings suggested that there was high homology between the strains gained in this study and those previously obtained in China, including recent epidemic strains.

Fig. 1 Phylogenetic analysis of the whole genome of HAdV-4. The phylogenetic tree was constructed by the neighbor-joining method and the Kimura two-parameter model using 1,000 replicates. The whole-genome sequences of HAdV-4 previously gained in China are indicated by cyan dots. Pink dots indicate the prototype strain and vaccine strains. Strains gained in this study are indicated by red dots

Phylogenetic analysis of the Hexon, Penton base, and Fiber genes

Hexon, Penton base, and Fiber gene sequences were successfully obtained from all 11 HAdV-4 positive samples (Supplementary Table 3), among which the nucleotide and amino acid homologies were 99.9–100% for Hexon, 99.9–100% for Penton base, 99.7–100% for Fiber. The genetic distances were 0.000 for Hexon, 0.000 for Penton base, and 0.001 for Fiber. Based on the Genbank, there were 82, 79, and 82 reference sequences of Hexon, Penton base, and Fiber genes obtained, respectively (Supplementary Table 5).

According to the phylogenetic analysis of Hexon, Penton base, and Fiber, there were also two phylogenetic branches of HAdV-4: 4a and 4p (Fig. 2). Similar to the whole-genome phylogenetic analysis, the 11 isolated strains gained in this study, strains previously gained in China and most pandemic strains since the 1980s all over the word were located in the HAdV-4a branch. The prototype strain and vaccine strains were in the same branch (4p) as most of the prevalent strains before the 1980s and several strains discovered in USA after that. The phylogenetic tree based on the Hexon gene sequences (Fig. 2A) displayed that the nucleotide and amino acid sequence identities on the Hexon genes of the HAdV-4 isolates obtained in this study and recent epidemic strains in China were 99.8–100%, respectively, with the genetic distance of 0.000. The mean genetic distances within group of 4a and 4p were 0.000, respectively, and the mean genetic distance between groups of 4a and 4p was 0.029. The strains from different countries did not exhibit significant geographical clustering. The phylogenetic tree based on the Penton base gene sequences (Fig. 2B) displayed that the nucleotide and amino acid sequence identities on the Penton base genes of the HAdV-4 isolates obtained in this study and recent epidemic strains in China were 99.6–100% and 99.8–100%, respectively, with the genetic distance of 0.001. The mean genetic distances within group of 4a and 4p were 0.002 and 0.000, respectively, and the mean genetic distance between groups of 4a and 4p was 0.030. The 11 Penton base gene sequences were clustered with the strain from Beijing (BJ14) in China and strains discovered in USA from 2009 to 2020, with the Bootstrap value of 87%. The phylogenetic tree based on the Fiber gene sequences (Fig. 2C) displayed that the nucleotide and amino acid sequence identities on the Fiber genes of the HAdV-4 isolates obtained in this study and recent epidemic strains in China were 99.4–100%, respectively, with the genetic distance of 0.001. The mean genetic distances within group of 4a and 4p were 0.001 and 0.000, respectively, and the mean genetic distance between groups of 4a and 4p was 0.020. The 11 Fiber gene sequences, except for BCH20190735, all clustered together with sequences previously obtained in China, with the Bootstrap value of approximately 62%. BCH20190735 mainly clustered together with strains discovered in USA from 2010 to 2023, with the Bootstrap value of only 50%.

Fig. 2 Phylogenetic analysis of three major capsid protein genes. The phylogenetic trees of (A) Hexon, (B) Penton base, and (C) Fiber genes were constructed by the neighbor-joining method and the Kimura two-parameter model using 1,000 replicates. The three major capsid protein gene sequences of HAdV-4 previously gained in China are indicated by cyan dots. Pink dots indicate the prototype strain and vaccine strains. Sequences of isolates gained in this study are indicated by red dots

Amino acid variation analysis

In comparison with the HAdV-4 prototype strain, there were 9 amino acid substitutions (S138A, D139N, A147V, G199D, K214N, P240T, S256G, T258N, and T289K) of all 11 sequences obtained in this study in the Loop1 region of Hexon protein (Fig. 3A), which were observed in the HAdV-4a subtype, but were not found in the HAdV-4p subtype. One amino acid substitution (N432T) occurred in the Loop2 region of Hexon protein (Fig. 3A), which was found in the HAdV-4a subtype, but was not found in the HAdV-4p subtype except for 5 strains isolated from USA.

Compared with the prototype strain, all 11 sequences obtained in this study had 6 amino acid substitutions (S308A, A310T, G321D, A333V, E339K, and D353E) in the RGD Loop region and 1 amino acid substitution (D158N) in the HVR1 region of Penton base protein (Fig. 3B), which were observed in the HAdV-4a subtype, but were not found in the HAdV-4p subtype.

Compared with the prototype strain, the 11 sequences did not have any amino acid mutations in the key regions binding to CAR, but had 3 amino acid substitutions (K329R, H396I, and C425E) in the Knob region of Fiber protein (Fig. 3C), which were also observed in the HAdV-4a subtype, but were not found in the HAdV-4p subtype.

Fig. 3 Amino acid variation analysis of three major capsid proteins. (A) Amino acid in the Loop1 and Loop2 of Hexon. (B) Amino acid in the RGD Loop and HVR1 of Penton base. (C) Amino acid in the key regions binding to CAR and Knob of Fiber. In the HAdV-4 prototype strain RI-67, the position of Loop1 was at 135–297 amino acid, and that of Loop2 was at 401–451 amino acid of Hexon. The position of RGD Loop was at 295–353 amino acid, and that of HVR1 was at 146–165 amino acid of Penton base. The regions binding to CAR were 253, 255, 256, and 274 amino acid location, and that of Knob was 318–425 amino acid location of Fiber

Nucleotide variation analysis of ITRs

Through the nucleotide variation analysis of the ITR region (Fig. 4), it was found that the majority of HAdV-4 sequences in China, including all 11 isolates obtained in this study, and most prevalent strains from other countries since 1978 had NF-I binding sites. However, it was not found in the ITRs of the HAdV-4p subtype and the simian adenovirus (SAdV) either. The NF-I in HAdV-4 was almost identical to that in species B.

Fig. 4 Nucleotide variation analysis of the ITR region. The 11 ITR gene sequences gained in this study, the prototype strain, vaccine strains, ITR gene sequences gained in China in the past, HAdV-4 strain that was first found NF-I binding sites adapting to host (Genbank accession number: KX384956, V0014/France/1978), and other HAdV types except HAdV-4 are all shown in the Figure. In the V0014 strain, the NF-I was 20–33 nucleotide location of the part of the ITR sequence shown in the figure

Recombination analysis

One of the essential mechanisms of HAdV evolution is gene recombination. Previous studies have shown that HAdV-4 is an animal-derived virus from interspecific recombination. The genome skeleton of the virus is derived from SAdV-26, and the Loop1 region of the Hexon gene is embedded with HAdV-16 [18]. By Simplot v3.5.1 software, the recombination analysis was conducted on the two whole-genome sequences gained in this study and the prototype strain. There was no new recombination.

Discussion

This study is the largest study in China on the HAdV-4 acute respiratory tract infection in children with the widest geographic coverage and the largest number of included study centers to date. This prospective multicenter study showed that the positive detection rate of HAdV-4 in children hospitalized due to ARI was 0.39% in the total samples and 7.05% of the HAdV positive samples over the course of the study. Li et al. isolated HAdV-4 samples from ARI children hospitalized or treated in the outpatient and emergency department in four provinces of Northern and Southern China during 2013 to 2014. The detection rate of HAdV-4 in the total samples was 0.11%, while 2.99% in HAdV positive samples [1], which was lower than that in this study. On the one hand, this may be related to the short duration of the study and the fact that only nasopharyngeal swab samples were used. On the other hand, it suggests that the incidence rate of HAdV-4 in China has shown an increasing trend in recent years, which needs more attention. There is a relatively large difference in the positive detection rate of HAdV-4 from relevant foreign studies, ranging from 0.04 to 25.13% in the total samples and 2.07–26.9% in the HAdV positive samples [24–26]. The reasons may be that most of the studies abroad are single-center studies and the different research areas, testing methods, the number of included patients, the age of the patients, the source and collection time of the samples, the duration of the study, the prevalence of adenovirus at that time, and so on. Based on previous studies, Coleman et al. found that HAdV-4 mainly occurred in military personnel, accounting for 88.5% of all cases, and the incidence rate in the general population, including children, was only 11.5%, which was low [13].

In this study, the main manifestations of children with HAdV-4 infection were fever and cough. Two children had conjunctivitis. Two children were diagnosed with severe pneumonia and developed serious complications. Coleman et al. reported that HAdV-4 infection could cause common respiratory diseases such as URTI, pneumonia and ocular diseases such as conjunctivitis, corneal conjunctivitis, etc. The severity of the diseases varied from mild/self-limiting to serious, even death, and hospitalization frequently occurred [13]. Most domestic and foreign literatures reported that respiratory diseases were most common in HAdV-4 infection. Compared with other common respiratory viruses, HAdV infection including HAdV-4 is more likely to lead to fever (body temperature ≥ 38℃), and the frequency of shortness of breath and dyspnea is relatively low [27]. Among respiratory HAdVs, HAdV-3, HAdV-4 and HAdV-7 are mainly associated with severe infection, especially HAdV-7, which has a stronger replication ability and virulence, and can promote and exacerbate cytokine responses, leading to more severe respiratory inflammation [28]. However, in a few countries, such as Vietnam, Greece, Nigeria, Tunisia, Türkiye, Saudi Arabia and Iraq, ocular diseases were more common in the reported HAdV-4 cases [13]. The reason may be the bias because of less HAdV-4 cases reported in these countries. Japan experienced multiple HAdV-4 epidemics from 1979 to 2006 [29, 30], in which approximately 82.3% of HAdV-4 cases were only ocular infections, especially keratoconjunctivitis [13], which may be related to the more active detection of HAdV-4 ocular infection in Japan [31]. In a systematic review and meta-analysis of databases consisting of PubMed and Embase between January 2000 and January 2020, keratoconjunctivitis was most commonly caused by species D of HAdV, especially HAdV-8 [32]. Notably, HAdV-8 infection could cause more severe symptoms, such as pseudomembrane formation, conjunctival hyperemia, and bloody eye secretion [33]. In this study, All the patients improved and were discharged without death, which may be the bias because of the small sample size. Coleman et al. systematically reviewed 144 articles on HAdV-4 infection published between 1960 and 2020. There was a total of 14 related deaths reported in children, mainly in USA, Singapore, and China, all of which died of respiratory complications [13].

In this study, the whole-genome sequences of 2 strains and the Hexon, Penton base, Fiber sequences of 11 HAdV-4 clinical isolates were obtained to performed phylogenetic analyses. The phylogenetic trees of the whole-genome, Hexon, Penton base, and Fiber sequences based on the genetic distance all formed two branches (HAdV-4p and HAdV-4a), which were consistent with previous REA research results and related reports [1, 18]. We found that the prototype strain (RI-67 strain) from USA belonged to HAdV-4p, which was mainly isolated before the 1980s. Recently, only four HAdV-4p strains were detected, which were from 2000, 2001, 2004, and 2015 in USA, respectively. HAdV-4a first appeared in France in 1978 and has been monitored in Japan, USA, China and other countries since then. In recent years, the detection frequency of HAdV-4a has gradually increased in various countries, gradually replacing HAdV-4p as the main epidemic strain, which is basically consistent with previous research conclusions [1]. All the HAdV-4 strains in China, including the clinical strains gained in this study, have always been situated in the same branch (HAdV-4a) as most of the foreign strains since the 1980s, and the mean genetic distance within the group was very close (≤ 0.002), indicating that the strains obtained in this study had high homology with most strains from different countries and regions, and the HAdV-4 genome was relatively stable in time and geographical space, which would facilitate the immune protection effect of the vaccine, as found by Li et al. [1]. HAdV-4a was the mainly subtype of HAdV-4 in China. Based on the homology analysis, the nucleotide and amino acid sequence identities on the whole-genomes and three genes of the HAdV-4 isolates obtained in this study and recent epidemic strains in China were not less than 98%, respectively, and the mean genetic distance was very close (≤ 0.001), indicating that the genomes of HAdV-4 strains prevalent in China had high conservation and stability. Recently, Gonzalez et al. reported HAdV-4 could be divided into two phylogroups (PGs): PGs I and II, comprising the prototype (p)-like (4p) and a-like (4a) genomes, respectively [34]. Previous studies have shown that the vaccines of HAdV-4 were live oral formulations of the nonattenuated p-like strains exclusively licensed for military use [35–37], so it would be necessary to develop new vaccines.

In comparison with the prototype strain, the HAdV-4 isolates obtained in this study had amino acid mutations in the antigen neutralizing sites of the Hexon protein, the HVR1 and RGD Loop regions of Penton base protein, and the Knob region of Fiber protein. The HAdV-4 strains prevalent in China exhibited approximately identical amino acid mutations with those belonging to the HAdV-4a subtype abroad. Similar mutations were also reported in previous studies [1]. However, except for the amino acid substitution (N432T) occurring in the Loop2 region of Hexon protein, which was found in the 5 strains (Genbank accession numbers: KX384957, KX384946, AP014852, EF371058 and AP014853) isolated from USA in 1981, 1986, 2000, 2001 and 2004 of HAdV-4p, these mutations were almost not found in HAdV-4p, indicating that these mutations might be related to the differences in virulence, pathogenicity, and prevalence between HAdV-4a and 4p. Tian et al. reported that a monoclonal antibody, MN4b, had strong neutralizing activity against HAdV-4 and could recognize a conformational epitope (418AGSEK422) in HVR7 of the Hexon protein. A recombinant virus, rAd3-A4R7-1 (containing the related HVR7 neutralizing epitope of HAdV-4 in the Hexon region of HAdV-3), was successfully constructed in vitro and successfully induced an anti-serum that could inhibited HAdV-4 infection. Previous studies and this study all showed that the amino acids of the above epitope were extremely conserved and no amino acid mutations were found, which would provide a new idea for the prevention and treatment of HAdV-4 in the future [38].

One of the proverbial features in HAdV genetics is recombination, which is also an important factor driving HAdV evolution [39]. Previous studies found that HAdV-4 originated from zoonotic diseases, which were generated by recombination of SAdV-26 genome and HAdV-16 Hexon gene [18]. The same results were obtained from the recombination analysis of the two HAdV-4 strains gained in this study, indicating that the two strains were evolved from the prototype strain. In addition, the majority of the sequences in China (including all the 11 isolates obtained in this study) and most of the sequences abroad in recent years found NF-I in the ITR region. This motif existed in almost all the types of HAdV, but not in SAdVs, HAdV-4 prototype strain, and simultaneously circulating isolates, including the vaccine strains. Moreover, NF-I in HAdV-4 was almost identical to that in species B, which was the same as Dehghan’s finding, so it was speculated that it might be derived from the recombination of species B [18]. NF-I is necessary for effective virus replication. It may allow the virus to expand to the immune immature population, and allow HAdV-4 to adapt to new hosts, which was served as an example of the molecular evolutionary of zoonotic and host adaptation for both “new” and “urgent” human pathogens [17]. The recombination event first appeared in 1978 (Genbank accession number: KX384956, V0014/France/1978) [40]. This will further explain why the incidence rate of HAdV-4 has gradually increased in recent years. However, the NF-I motif is located at the forefront of the genome, making it difficult to sequence [41], which may be the reason why this motif was not found in the 5 strains (Genbank accession numbers: OK323253, OK323260, OK323261, OK323262 and OK323263) isolated from Beijing, China in 2019. In addition, no new recombination of HAdV-4 was found in this study, which was consistent with the results of other studies [41], indicating that the HAdV-4 genome circulating in recent years was relatively stable, and the vaccine could maintain long-term effectiveness.

There were also some limitations in this study. Firstly, although the samples came from six hospitals in the north and south of China, China had a vast territory and the findings gained in this study could not represent the HAdV-4 infection in ARI children in all regions of China. Secondly, this study only included hospitalized ARI children and the number of HAdV-4 positive samples was limited.

Conclusions

This multicenter study showed that the detection rate of HAdV-4 in children hospitalized with ARI in China between 2017 and 2020 was relatively low, and the detection rate of HAdV-4 was 0.39% in the total samples and 7.05% of all HAdV positive samples. ARI caused by HAdV-4 may be severe and can also be accompanied by eye diseases. HAdV-4 prevalent in China belonged to the HAdV-4a subtype and the genome was high conservative and stable. This study further clarified the prevalence and genetic characteristics of HAdV-4 epidemic in China and provided reference for the monitoring, prevention and control of HAdV-4, as well as the research and development of vaccines and drugs.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Supplementary Material 4

Supplementary Material 5

Acknowledgements

We would like to express our sincere appreciation to our institutes and universities.

Author contributions

JW, QF, YD, and ZX conceived and designed the study, wrote the manuscript. JW, QF and YD performed the experiments and prepared the figures. JW, QF, YD, JA, YZ, RW, XC and ZX analyzed the data. JW, QF, YD, and ZX checked and finalized the manuscript. GL, YS, CL, RJ, YShang, and BX provided resources and data curation. ZX provided resources. JW and QF contributed equally to this work. All authors read and approved the final manuscript.

Funding

This work was supported by National Natural Science Foundation of China (82072266), National Science and Technology Major Special Project (2017ZX10103004–004) and CAMS Innovation Fund for Medical Sciences (CIFMS) (2019-I2M-5-026).

Data availability

Data is provided within the manuscript or supplementary information files. Sequences generated in this study have been deposited in the Genbank database with the accession numbers from OP715915 to OP715949.

Declarations

Ethics approval and consent to participate

This study was approved by the Institutional Ethics and Review Committees of the Beijing Children’s Hospital affiliated to Capital Medical University (2017-k-15, 2019-k-357), which was conducted in accordance with the Declaration of Helsinki (revised in 2013). Parents/legal-guardian of each child signed an informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Abbreviations

HAdV Human adenovirus

DNA Deoxyribonucleic acid

ARI Acute respiratory infection

PCR Polymerase chain reaction

ITR Inverted terminal repeat

NF-1 Nuclear factor 1

REA Restriction enzyme analysis

HVR Hypervariable region

NCPAP Nasal continuous positive airway pressure

PICU Pediatric intensive care unit

URTI Upper respiratory tract infection

CAR Coxsackie-adenovirus receptor

SAdV Simian adenovirus

PG Phylogroup

ChAdV Chimpanzee adenovirus

HEV Human enterovirus

HRV Human rhinovirus

RSV Respiratory syncytial virus

HMPV Human metapneumovirus

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jinjin Wang and Qianyu Feng contributed equally to this work.
==== Refs
References

1. Li H Mao NY Yu PB Yin J Jiang HB Zhang B Genetic characteristics of human adenovirus type 4 in acute respiratory tract infection in four provinces of China from 2013 to 2014 J Virol 2018 34 06 850 9 10.13242/j.cnki.bingduxuebao.003463
Li H, Mao NY, Yu PB, Yin J, Jiang HB, Zhang B, et al. Genetic characteristics of human adenovirus type 4 in acute respiratory tract infection in four provinces of China from 2013 to 2014. J Virol. 2018;34(06):850–9. 10.13242/j.cnki.bingduxuebao.003463. (in Chinese).10.13242/j.cnki.bingduxuebao.003463
2. Davison AJ Benko M Harrach B Genetic content and evolution of adenoviruses J Gen Virol 2003 84 2895 908 10.1099/vir.0.19497-0 14573794
Davison AJ, Benko M, Harrach B. Genetic content and evolution of adenoviruses. J Gen Virol. 2003;84:2895–908. 10.1099/vir.0.19497-0.14573794 10.1099/vir.0.19497-0
3. Madisch I Harste G Pommer H Heim A Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy J Virol 2005 79 24 15265 76 10.1128/JVI.79.24.15265-15276.2005 16306598
Madisch I, Harste G, Pommer H, Heim A. Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy. J Virol. 2005;79(24):15265–76. 10.1128/JVI.79.24.15265-15276.2005.16306598 10.1128/JVI.79.24.15265-15276.2005
4. Madisch I Hofmayer S Moritz C Grintzalis A Hainmueller J Pring-Akerblom P Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design J Virol 2007 81 15 8270 81 10.1128/JVI.00048-07 17522221
Madisch I, Hofmayer S, Moritz C, Grintzalis A, Hainmueller J, Pring-Akerblom P, et al. Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design. J Virol. 2007;81(15):8270–81. 10.1128/JVI.00048-07.17522221 10.1128/JVI.00048-07
5. Dongliu Y Guoliang Y Haocheng X Shuaijia Q Li B Yanglei J Outbreak of acute febrile respiratory illness caused by human adenovirus B P14H11F14 in a military training camp in Shandong China Arch Virol 2016 161 9 2481 9 10.1007/s00705-016-2949-x 27352268
Dongliu Y, Guoliang Y, Haocheng X, Shuaijia Q, Li B, Yanglei J, et al. Outbreak of acute febrile respiratory illness caused by human adenovirus B P14H11F14 in a military training camp in Shandong China. Arch Virol. 2016;161(9):2481–9. 10.1007/s00705-016-2949-x.27352268 10.1007/s00705-016-2949-x
6. Rao HX Ma YC Jiang SY Wang XW Shi Y Zhao SC Etiological analysis of cases of acute respiratory tract infection in Qinghai, China J Pathogen Biology 2014 9 05 430 3 10.13350/j.cjpb.140511
Rao HX, Ma YC, Jiang SY, Wang XW, Shi Y, Zhao SC, et al. Etiological analysis of cases of acute respiratory tract infection in Qinghai, China. J Pathogen Biology. 2014;9(05):430–3. 10.13350/j.cjpb.140511. (in Chinese).10.13350/j.cjpb.140511
7. Otto WR Lamson DM Gonzalez G Weinberg GA Pecora ND Fisher BT Fatal neonatal Sepsis Associated with Human Adenovirus Type 56 infection: genomic analysis of three recent cases detected in the United States Viruses 2021 13 6 1105 10.3390/v13061105 34207791
Otto WR, Lamson DM, Gonzalez G, Weinberg GA, Pecora ND, Fisher BT, et al. Fatal neonatal Sepsis Associated with Human Adenovirus Type 56 infection: genomic analysis of three recent cases detected in the United States. Viruses. 2021;13(6):1105. 10.3390/v13061105.34207791 10.3390/v13061105
8. Louie JK Kajon AE Holodniy M Guardia-LaBar L Lee B Petru AM Severe pneumonia due to adenovirus serotype 14: a new respiratory threat? Clin Infect Dis 2008 46 3 421 5 10.1086/525261 18173356
Louie JK, Kajon AE, Holodniy M, Guardia-LaBar L, Lee B, Petru AM, et al. Severe pneumonia due to adenovirus serotype 14: a new respiratory threat? Clin Infect Dis. 2008;46(3):421–5. 10.1086/525261.18173356 10.1086/525261
9. Purkayastha A Su J McGraw J Ditty SE Hadfield TL Seto J Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease J Clin Microbiol 2005 43 7 3083 94 10.1128/JCM.43.7.3083-3094.2005 16000418
Purkayastha A, Su J, McGraw J, Ditty SE, Hadfield TL, Seto J, et al. Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease. J Clin Microbiol. 2005;43(7):3083–94. 10.1128/JCM.43.7.3083-3094.2005.16000418 10.1128/JCM.43.7.3083-3094.2005
10. Faden H Gallagher M Disseminated infection due to Adenovirus Type 4 Clin Pediatr (Phila) 2016 19 6 427 9 10.1177/000992288001900608
Faden H, Gallagher M. Disseminated infection due to Adenovirus Type 4. Clin Pediatr (Phila). 2016;19(6):427–9. 10.1177/000992288001900608.10.1177/000992288001900608
11. Ou ZY Zeng QY Wang FH Xia HM Lu JP Xia JQ Retrospective study of adenovirus in autopsied pulmonary tissue of pediatric fatal pneumonia in South China BMC Infect Dis 2008 8 122 10.1186/1471-2334-8-122 18803877
Ou ZY, Zeng QY, Wang FH, Xia HM, Lu JP, Xia JQ, et al. Retrospective study of adenovirus in autopsied pulmonary tissue of pediatric fatal pneumonia in South China. BMC Infect Dis. 2008;8:122. 10.1186/1471-2334-8-122.18803877 10.1186/1471-2334-8-122
12. Chen YJ Li JM Zhou JM Li G Fang SS Liu Q Epidemiological analysis of an outbreak of respiratory tract infection caused by adenovirus type 4 SOUTH CHINA J Prev Med 2014 40 05 472 4 10.13217/j.scjpm.2
Chen YJ, Li JM, Zhou JM, Li G, Fang SS, Liu Q, et al. Epidemiological analysis of an outbreak of respiratory tract infection caused by adenovirus type 4. SOUTH CHINA J Prev Med. 2014;40(05):472–4. 10.13217/j.scjpm.2. 014.0472.(in Chinese).10.13217/j.scjpm.2
13. Coleman KK Robie ER Abdelgadir A Kozhumam AS Binder RA Gray GC Six decades of human adenovirus type 4 infections reviewed: increasing infections among civilians are a matter of concern Clin Infect Dis 2021 73 4 740 6 10.1093/cid/ciab146 33693635
Coleman KK, Robie ER, Abdelgadir A, Kozhumam AS, Binder RA, Gray GC. Six decades of human adenovirus type 4 infections reviewed: increasing infections among civilians are a matter of concern. Clin Infect Dis. 2021;73(4):740–6. 10.1093/cid/ciab146.33693635 10.1093/cid/ciab146
14. Coleman KK Wong CC Jayakumar J Nguyen TT Wong AWL Yadana S Adenoviral Infections in Singapore: should New Antiviral therapies and vaccines be adopted? J Infect Dis 2020 221 4 566 77 10.1093/infdis/jiz489 31563943
Coleman KK, Wong CC, Jayakumar J, Nguyen TT, Wong AWL, Yadana S, et al. Adenoviral Infections in Singapore: should New Antiviral therapies and vaccines be adopted? J Infect Dis. 2020;221(4):566–77. 10.1093/infdis/jiz489.31563943 10.1093/infdis/jiz489
15. Chen HL Chiou SS Hsiao HP Ke GM Lin YC Lin KH Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001–2002 J Trop Pediatr 2004 50 5 279 84 10.1093/tropej/50.5.279 15510759
Chen HL, Chiou SS, Hsiao HP, Ke GM, Lin YC, Lin KH, et al. Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001–2002. J Trop Pediatr. 2004;50(5):279–84. 10.1093/tropej/50.5.279.15510759 10.1093/tropej/50.5.279
16. Ye XM Xiao LJ Zheng XH Wang JL Shu T Feng Y Seroprevalence of neutralizing antibodies to human adenovirus type 4 and 7 in healthy populations from Southern China Front Microbiol 2018 9 3040DOI 10.3389/fmicb.2018.03040 30619131
Ye XM, Xiao LJ, Zheng XH, Wang JL, Shu T, Feng Y, et al. Seroprevalence of neutralizing antibodies to human adenovirus type 4 and 7 in healthy populations from Southern China. Front Microbiol. 2018;9:3040DOI. 10.3389/fmicb.2018.03040.30619131 10.3389/fmicb.2018.03040
17. Zhang J Kang J Dehghan S Sridhar S Lau SKP Ou J A survey of recent adenoviral respiratory pathogens in Hong Kong reveals emergent and recombinant human adenovirus type 4 (HAdV-E4) circulating in civilian populations Viruses 2019 11 2 129 10.3390/v11020129 30708990
Zhang J, Kang J, Dehghan S, Sridhar S, Lau SKP, Ou J, et al. A survey of recent adenoviral respiratory pathogens in Hong Kong reveals emergent and recombinant human adenovirus type 4 (HAdV-E4) circulating in civilian populations. Viruses. 2019;11(2):129. 10.3390/v11020129.30708990 10.3390/v11020129
18. Dehghan S Seto J Liu EB Walsh MP Dyer DW Chodosh J Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events Virology 2013 443 2 197 207 10.1016/j.virol.2013.05.014 23763770
Dehghan S, Seto J, Liu EB, Walsh MP, Dyer DW, Chodosh J, et al. Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events. Virology. 2013;443(2):197–207. 10.1016/j. virol.2013.05.014.23763770 10.1016/j.virol.2013.05.014
19. Ariga T Shimada Y Ohgami K Tagawa Y Ishiko H Aoki K New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in Japan J Clin Microbiol 2004 42 8 3644 8 10.1128/JCM.42.8.3644-3648.2004 15297510
Ariga T, Shimada Y, Ohgami K, Tagawa Y, Ishiko H, Aoki K, et al. New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in Japan. J Clin Microbiol. 2004;42(8):3644–8. 10.1128/JCM.42.8.3644-3648.2004.15297510 10.1128/JCM.42.8.3644-3648.2004
20. Baker AT Greenshields-Watson A Coughlan L Davies JA Uusi-Kerttula H Cole DK Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions Nat Commun 2019 10 1 741 10.1038/s41467-019-08599-y 30765704
Baker AT, Greenshields-Watson A, Coughlan L, Davies JA, Uusi-Kerttula H, Cole DK, et al. Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions. Nat Commun. 2019;10(1):741. 10.1038/s41467-019-08599-y.30765704 10.1038/s41467-019-08599-y
21. Tian XG Chen Y Li HT Ran Y Zhou ZC Chen SY Characterization of a replication-competent vector encoding DsRed based on a human adenovirus type 4 a-like strain Virus Res 2019 270 197662 10.1016/j.virusres.2019.197662 31301331
Tian XG, Chen Y, Li HT, Ran Y, Zhou ZC, Chen SY, et al. Characterization of a replication-competent vector encoding DsRed based on a human adenovirus type 4 a-like strain. Virus Res. 2019;270:197662. 10.1016/j.virusres.2019.197662.31301331 10.1016/j.virusres.2019.197662
22. Hoke CH Jr Snyder CE Jr History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system Vaccine 2013 31 12 1623 32 10.1016/j.vaccine.2012.12.029 23291475
Hoke CH Jr, Snyder CE Jr. History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system. Vaccine. 2013;31(12):1623–32. 10.1016/j.vaccine.2012.12.029.23291475 10.1016/j.vaccine.2012.12.029
23. Lu X Erdman DD Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene Arch Virol 2006 151 8 1587 602 10.1007/s00705-005-0722-7 16502282
Lu X, Erdman DD. Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene. Arch Virol. 2006;151(8):1587–602. 10.1007/s00705-005-0722-7.16502282 10.1007/s00705-005-0722-7
24. Probst V Datyner EK Haddadin Z Rankin DA Hamdan L Rahman HK Human adenovirus species in children with acute respiratory illnesses J Clin Virol 2021 134 104716 10.1016/j.jcv.2020.104716 33360858
Probst V, Datyner EK, Haddadin Z, Rankin DA, Hamdan L, Rahman HK, et al. Human adenovirus species in children with acute respiratory illnesses. J Clin Virol. 2021;134:104716. 10.1016/j.jcv.2020.104716.33360858 10.1016/j.jcv.2020.104716
25. Barrero PR Valinotto LE Tittarelli E Mistchenko AS Molecular typing of adenoviruses in pediatric respiratory infections in Buenos Aires, Argentina (1999–2010) J Clin Virol 2012 53 2 145 50 10.1016/j.jcv.2011.11.001 22138300
Barrero PR, Valinotto LE, Tittarelli E, Mistchenko AS. Molecular typing of adenoviruses in pediatric respiratory infections in Buenos Aires, Argentina (1999–2010). J Clin Virol. 2012;53(2):145–50. 10.1016/j.jcv.2011.11.001.22138300 10.1016/j.jcv.2011.11.001
26. Nakamura H Fujisawa T Suga S Taniguchi K Nagao M Ito M Species differences in circulation and inflammatory responses in children with common respiratory adenovirus infections J Med Virol 2018 90 5 873 80 10.1002/jmv.25032 29350418
Nakamura H, Fujisawa T, Suga S, Taniguchi K, Nagao M, Ito M, et al. Species differences in circulation and inflammatory responses in children with common respiratory adenovirus infections. J Med Virol. 2018;90(5):873–80. 10.1002/jmv.25032.29350418 10.1002/jmv.25032
27. Feng LZ Lai SJ Li F Ye XF Li S Ren X Viral etiologies of hospitalized pneumonia patients aged less than five years in six provinces, 2009–2012 Chin J Epidemiol 2014 35 6 646 9 10.3760/cma.j.issn.0254-6450.2014.06.007
Feng LZ, Lai SJ, Li F, Ye XF, Li S, Ren X, et al. Viral etiologies of hospitalized pneumonia patients aged less than five years in six provinces, 2009–2012. Chin J Epidemiol. 2014;35(6):646–9. 10.3760/cma.j.issn.0254-6450.2014.06.007. (in Chinese).10.3760/cma.j.issn.0254-6450.2014.06.007
28. Fu YX Tang ZZ Ye ZX Mo S Tian XG Ni K Human adenovirus type 7 infection causes a more severe disease than type 3 BMC Infect Dis 2019 19 1 36 10.1186/s12879-018-3651-2 30626350
Fu YX, Tang ZZ, Ye ZX, Mo S, Tian XG, Ni K, et al. Human adenovirus type 7 infection causes a more severe disease than type 3. BMC Infect Dis. 2019;19(1):36. 10.1186/s12879-018-3651-2.30626350 10.1186/s12879-018-3651-2
29. Aoki K Kato M Ohtsuka H Ishii K Nakazono N Sawada H Clinical and aetiological study of adenoviral conjunctivitis, with special reference to adenovirus types 4 and 19 infections Br J Ophthalmol 1982 66 12 776 80 10.1136/bjo.66.12.776 6293531
Aoki K, Kato M, Ohtsuka H, Ishii K, Nakazono N, Sawada H. Clinical and aetiological study of adenoviral conjunctivitis, with special reference to adenovirus types 4 and 19 infections. Br J Ophthalmol. 1982;66(12):776–80. 10.1136/bjo.66.12.776.6293531 10.1136/bjo.66.12.776
30. Matsui K Shimizu H Yoshida A Nagaoka E Nishio O Okuda K Monitoring of adenovirus from conjunctival scrapings in Japan during 2005–2006 J Med Virol 2008 80 6 997 1003 10.1002/jmv.21175 18428122
Matsui K, Shimizu H, Yoshida A, Nagaoka E, Nishio O, Okuda K. Monitoring of adenovirus from conjunctival scrapings in Japan during 2005–2006. J Med Virol. 2008;80(6):997–1003. 10.1002/jmv.21175.18428122 10.1002/jmv.21175
31. Aoki K Tagawa Y A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan Int Ophthalmol Clin 2002 42 1 49 54 10.1097/00004397-200201000-00008 12189615
Aoki K, Tagawa Y. A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Int Ophthalmol Clin. 2002;42(1):49–54. 10.1097/00004397-200201000-00008.12189615 10.1097/00004397-200201000-00008
32. Gu J Su QQ Zuo TT Chen YB Adenovirus diseases: a systematic review and meta-analysis of 228 case reports Infection 2021 49 1 1 13 10.1007/s15010-020-01484-7 32720128
Gu J, Su QQ, Zuo TT, Chen YB. Adenovirus diseases: a systematic review and meta-analysis of 228 case reports. Infection. 2021;49(1):1–13. 10.1007/s15010-020-01484-7.32720128 10.1007/s15010-020-01484-7
33. Wang J Ning X Xu Y Wang R Guo X Xu J Etiological Study of Acute Conjunctivitis caused by human adenovirus in Shanxi Province, China, between 2016 and 2019 Microbiol Spectr 2023 11 4 e0015923 10.1128/spectrum.00159-23 37486235
Wang J, Ning X, Xu Y, Wang R, Guo X, Xu J, et al. Etiological Study of Acute Conjunctivitis caused by human adenovirus in Shanxi Province, China, between 2016 and 2019. Microbiol Spectr. 2023;11(4):e0015923. 10.1128/spectrum.00159-23.37486235 10.1128/spectrum.00159-23
34. Gonzalez G Bair CR Lamson DM Watanabe H Panto L Carr MJ Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor Virology 2019 538 11 23 10.1016/j.virol.2019.08.028 31550608
Gonzalez G, Bair CR, Lamson DM, Watanabe H, Panto L, Carr MJ, et al. Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor. Virology. 2019;538:11–23. 10.1016/j.virol.2019.08.028.31550608 10.1016/j.virol.2019.08.028
35. Gutekunst RR White RJ Edmondson WP Chanock RM Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection Am J Epidemiol 1967 86 2 341 9 10.1093/oxfordjournals.aje.a120744 4293744
Gutekunst RR, White RJ, Edmondson WP, Chanock RM. Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection. Am J Epidemiol. 1967;86(2):341–9. 10.1093/oxfordjournals.aje.a120744.4293744 10.1093/oxfordjournals.aje.a120744
36. van der Veen J Abarbanel MF Oei KG Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy J Hyg (Lond) 1968 66 4 499 511 10.1017/s0022172400028242 4303951
van der Veen J, Abarbanel MF, Oei KG. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy. J Hyg (Lond). 1968;66(4):499–511. 10.1017/s0022172400028242.4303951 10.1017/s0022172400028242
37. Lynch BL Dean J Brady D De Gascun C Adenovirus Type 4 respiratory infections among civilian adults, Northeastern United States, 2011–2015 Emerg Infect Dis 2018 24 7 1392 3 10.3201/eid2407.180137 29912699
Lynch BL, Dean J, Brady D, De Gascun C. Adenovirus Type 4 respiratory infections among civilian adults, Northeastern United States, 2011–2015. Emerg Infect Dis. 2018;24(7):1392–3. 10.3201/eid2407.180137.29912699 10.3201/eid2407.180137
38. Tian X Qiu H Zhou Z Wang S Fan Y Li X Identification of a critical and Conformational Neutralizing Epitope in human adenovirus type 4 Hexon J Virol 2018 92 2 e01643 17 10.1128/JVI.01643-17 29093098
Tian X, Qiu H, Zhou Z, Wang S, Fan Y, Li X, et al. Identification of a critical and Conformational Neutralizing Epitope in human adenovirus type 4 Hexon. J Virol. 2018;92(2):e01643–17. 10.1128/JVI.01643-17.29093098 10.1128/JVI.01643-17
39. Walsh MP Chintakuntlawar A Robinson CM Madisch I Harrach B Hudson NR Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis PLoS ONE 2009 4 6 e5635 10.1371/journal.pone.0005635 19492050
Walsh MP, Chintakuntlawar A, Robinson CM, Madisch I, Harrach B, Hudson NR, et al. Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis. PLoS ONE. 2009;4(6):e5635. 10.1371/journal.pone.0005635.19492050 10.1371/journal.pone.0005635
40. Houng HS Clavio S Graham K Kuschner R Sun W Russell KL Emergence of a new human adenovirus type 4 (Ad4) genotype: identification of a novel inverted terminal repeated (ITR) sequence from majority of Ad4 isolates from US military recruits J Clin Virol 2006 35 4 381 7 10.1016/j.jcv.2005.11.008 16406799
Houng HS, Clavio S, Graham K, Kuschner R, Sun W, Russell KL, et al. Emergence of a new human adenovirus type 4 (Ad4) genotype: identification of a novel inverted terminal repeated (ITR) sequence from majority of Ad4 isolates from US military recruits. J Clin Virol. 2006;35(4):381–7. 10.1016/j.jcv.2005.11.008.16406799 10.1016/j.jcv.2005.11.008
41. Li MZ Li J Kang L Gong C Luo M Wang X Genome sequencing reveals molecular epidemiological characteristics and new recombinations of adenovirus in Beijing, China, 2014–2019 J Med Virol 2023 95 12 e29284 10.1002/jmv.29284 38087446
Li MZ, Li J, Kang L, Gong C, Luo M, Wang X, et al. Genome sequencing reveals molecular epidemiological characteristics and new recombinations of adenovirus in Beijing, China, 2014–2019. J Med Virol. 2023;95(12):e29284. 10.1002/jmv.29284.38087446 10.1002/jmv.29284
